GLPG3667
GLPG3667-CL-112
Phase 1 small_molecule completed
Quick answer
GLPG3667 for Plaque Psoriasis is a Phase 1 program (small_molecule) at Lakefront Biotherapeutics NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lakefront Biotherapeutics NV
- Indication
- Plaque Psoriasis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed